LDL resistance to oxidation: Effects of lipid phenotype, autologous HDL and alanine

Clinica Chimica Acta

Volumn 379, Issue 1-2, 2007, Pages 95-100

  Baldi, Simona ^a   Frascerra, Silvia ^a   Ferrannini, Ele ^a   Natali, Andrea ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Anti oxidants; HDL oxidation; Lag phase; LDL oxidation

Indexed keywords

ALANINE; COPPER; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OXIDATION; PHENOTYPE; PRIORITY JOURNAL;

ADULT; ALANINE; COPPER; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; TRIGLYCERIDES;

EID: 33847615135     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.12.019     Document Type: Article

References (29)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320 (1989) 915-924
2. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 84 (2004) 1381-1478
3. Nakajima K., Nakano T., and Tanaka A. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta 367 (2006) 36-47
4. Grundy S.M. Oxidized LDL and atherogenesis: relation to risk factors for coronary heart disease. Clin Cardiol 16 (1993) I3-I5
5. Esterbauer H., Striegl H., Puhl H., and Dieber-Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Res Commun 6 (1989) 67-75
6. Jialal I., and Fuller C.J. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can J Cardiol 11 (1995) 97G-103G [Suppl G]
7. Cominacini L., Garbin U., Cenci B., et al. Predisposition to LDL oxidation during copper-catalyzed oxidative modification and its relation to alpha-tocopherol content in humans. Clin Chim Acta 204 (1991) 57-68
8. Kontush A., Hubner C., Finckh B., Kohlschutter A., and Beisiegel U. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach. Free Radic Res 24 (1996) 135-147
9. Chait A., Brazg R.L., Tribble D.L., and Krauss R.M. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 94 (1993) 350-356
10. Parthasarathy S., Barnett J., and Fong L.G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1044 (1990) 275-283
11. Sanguinetti S.M., Brites F.D., Fasulo V., et al. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients. Diabetes Nutr Metab 14 (2001) 27-36
12. Navab M., Hama S.Y., Anantharamaiah G.M., et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res 41 (2000) 1495-1508
13. Navab M., Hama S.Y., Cooke C.J., et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res 41 (2000) 1481-1494
14. Picard S., Talussot C., Serusclat A., Ambrosio N., and Berthezene F. Minimally oxidised LDL as estimated by a new method increase in plasma of type 2 diabetic patients with atherosclerosis or nephropathy. Diabetes Metab 22 (1996) 25-30
15. Van Gaal L.F., Zhang A., Steijaert M.M., and De Leeuw I.H. Human obesity: from lipid abnormalities to lipid oxidation. Int J Obes Relat Metab Disord 19 Suppl 3 (1995) S21-S26
16. Van Gaal L.F., Vertommen J., and De Leeuw I.H. The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects. Atherosclerosis 137 (1998) S39-S44 [Suppl]
17. Myara I., Alamowitch C., Michel O., et al. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients. Obes Res 11 (2003) 112-120
18. Balkan J., Kanbagli O., Mehmetcik G., Mutlu-Turkoglu U., Aykac-Toker G., and Uysal M. Increased lipid peroxidation in serum and low-density lipoproteins associated with aging in humans. Int J Vitam Nutr Res 72 (2002) 315-320
19. Mosinger B.J. Human low-density lipoproteins: oxidative modification and its relation to age, gender, menopausal status and cholesterol concentrations. Eur J Clin Chem Clin Biochem 35 (1997) 207-214
20. Schmuck A., Fuller C.J., Devaraj S., and Jialal I. Effect of aging on susceptibility of low-density lipoproteins to oxidation. Clin Chem 41 (1995) 1628-1632
21. Stulnig T.M., Jurgens G., Chen Q., et al. Properties of low density lipoproteins relevant to oxidative modifications change paradoxically during aging. Atherosclerosis 126 (1996) 85-94
22. Cherubini A., Zuliani G., Costantini F., et al. High vitamin E plasma levels and low low-density lipoprotein oxidation are associated with the absence of atherosclerosis in octogenarians. J Am Geriatr Soc 49 (2001) 651-654
23. Packard C.J. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 31 (2003) 1066-1069
24. de Man F.H., de Beer F., van der Laarse A., et al. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding. Atherosclerosis 153 (2000) 363-371
25. Callow J., Samra J.S., and Frayn K.N. Effect of infusion of a triacylglycerol emulsion on low-density lipoprotein composition and oxidizability. Atherosclerosis 137 (1998) 115-123
26. Visioli F., Bordone R., Perugini C., Bagnati M., Cau C., and Bellomo G. The kinetics of copper-induced LDL oxidation depend upon its lipid composition and antioxidant content. Biochem Biophys Res Commun 268 (2000) 818-822
27. Abdel-Maksoud M.F., and Hokanson J.E. The complex role of triglycerides in cardiovascular disease. Semin Vasc Med 2 (2002) 325-333
28. Raveh O., Pinchuk I., Fainaru M., and Lichtenberg D. Kinetics of lipid peroxidation in mixtures of HDL and LDL, mutual effects. Free Radic Biol Med 31 (2001) 1486-1497
29. Carantoni M., Abbasi F., Warmerdam F., et al. Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers. Arterioscler Thromb Vasc Biol 18 (1998) 762-767